4CPS-151 Optimisation programme of biological therapies in rheumatoid arthritis: results of create registry after 3 years

BACKGROUND: Dose optimisation (dose reduction or dose spacing) is a therapeutic strategy applied in patients with rheumatoid arthritis (RA) who have managed to maintain clinical remission. This strategy reduces the frequency of adverse effects and promotes cost savings. PURPOSE: Evaluate effectivene...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Hosp Pharm
Main Authors: Ruiz, S de la Fuente, Ugalde, P Font, Aranzana, M Cárdenas, Villegas, MC Castro, Gómez, M Romero, Castro, R Ortega, Guitiérrez, J Calvo, Vílchez, D Ruiz, Estévez, E Colllantes
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2018
Assuntos:
Section 4: Clinical pharmacy services
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535294/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.242
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados